Search research articles
Contact Us
Filters
Showing results (201-210 of 222) with videos related to
Page
of 23
Sort By:
The Journal of Infectious Diseases
|
May 7, 2014
A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development
Martina Sanderson-Smith, David M P De Oliveira, Julien Guglielmini, et al.
Plos Neglected Tropical Diseases
|
September 2, 2021
A framework for scabies control
Daniel Engelman, Michael Marks, Andrew C Steer, et al.
Clinical & Translational Immunology
|
October 4, 2024
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS-CoV-2 Omicron infection
Zheng Quan Toh, Jeremy Anderson, Nadia Mazarakis, et al.
Plos Medicine
|
June 25, 2019
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study
Gary J Weil, Joshua Bogus, Michael Christian, et al.
The New England Journal of Medicine
|
August 24, 2017
Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015
David A Watkins, Catherine O Johnson, Samantha M Colquhoun, et al.
The New England Journal of Medicine
|
November 12, 2021
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease
Andrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
Frontiers in Immunology
|
November 1, 2021
Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure
Melanie R Neeland, Samantha Bannister, Vanessa Clifford, et al.
Plos Neglected Tropical Diseases
|
March 3, 2021
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis
Alison Krentel, Nandha Basker, Madsen Beau de Rochars, et al.
Lancet (London, England)
|
June 11, 2019
The public health control of scabies: priorities for research and action
Daniel Engelman, Paul T Cantey, Michael Marks, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial
J Lee, A Dean, T Price, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 222) with videos related to
Sort By:
Page
of 23
The Journal of Infectious Diseases
|
May 7, 2014
A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development
Martina Sanderson-Smith, David M P De Oliveira, Julien Guglielmini, et al.
Plos Neglected Tropical Diseases
|
September 2, 2021
A framework for scabies control
Daniel Engelman, Michael Marks, Andrew C Steer, et al.
Clinical & Translational Immunology
|
October 4, 2024
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS-CoV-2 Omicron infection
Zheng Quan Toh, Jeremy Anderson, Nadia Mazarakis, et al.
Plos Medicine
|
June 25, 2019
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study
Gary J Weil, Joshua Bogus, Michael Christian, et al.
The New England Journal of Medicine
|
August 24, 2017
Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015
David A Watkins, Catherine O Johnson, Samantha M Colquhoun, et al.
The New England Journal of Medicine
|
November 12, 2021
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease
Andrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
Frontiers in Immunology
|
November 1, 2021
Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure
Melanie R Neeland, Samantha Bannister, Vanessa Clifford, et al.
Plos Neglected Tropical Diseases
|
March 3, 2021
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis
Alison Krentel, Nandha Basker, Madsen Beau de Rochars, et al.
Lancet (London, England)
|
June 11, 2019
The public health control of scabies: priorities for research and action
Daniel Engelman, Paul T Cantey, Michael Marks, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial
J Lee, A Dean, T Price, et al.
Page
of 23